Description
An antibiotic; active against β-hemolytic Streptoccus, S. pneumoniae, C. difficile, C. perfringens, and P. magnus Gram-positive bacteria (MICs = 0.12-1, 0.25-2, 4, 16, and 0.12 μg/ml, respectively); increases survival in a mouse model of lethal S. pyogenes infection from 4-64 mg/kg; increases body weight in chickens
Formal name: benzeneacetic acid, (2R,3R,4R,6S)-2-[(1S)-2-[[(2E,4E,6S,7S)-7-[(2R,4S,5S)-5-[(1E,3E,5E)-6-carboxy-1,3,5-hexatrienyl]tetrahydro-4-hydroxy-2-furanyl]-6-methoxy-5-methyl-2,4-octadienyl]amino]-1-[[[O-2,6-dideoxy-3-O-methyl-α-L-lyxo-hexopyranosyl-(1→4)-(O-2,6-dideoxy-3-O-methyl-β-L-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-3-O-methyl-α-L-lyxo-hexopyranosyl]oxy]methyl]-2-oxoethyl]tetrahydro-2,4-dihydroxy-5,5-dimethyl-6-[(1E,3Z)-1,3-pentadienyl]-2H-pyran-3-yl ester
Synonyms: Ganefromycin α
Molecular weight: 1,226.40
CAS: 114451-31-9
Purity: ≥95%
Formulation: A solid